CN Patent

CN104086551B — 化合物及其制备方法和用途

Assigned to Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology · Expires 2016-09-21 · 10y expired

What this patent protects

本发明提供了化合物及其制备方法和用途，该化合物为式I所示化合物或式I所示化合物的立体异构体、互变异构体、药物活性代谢物、可药用盐、水合物、溶剂化物或前药，其中，X、R 1 、R 2 如说明书所定义。该化合物能够作为激酶抑制剂。

USPTO Abstract

本发明提供了化合物及其制备方法和用途，该化合物为式I所示化合物或式I所示化合物的立体异构体、互变异构体、药物活性代谢物、可药用盐、水合物、溶剂化物或前药，其中，X、R 1 、R 2 如说明书所定义。该化合物能够作为激酶抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN104086551B
Jurisdiction
CN
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.